4-nitrophenylacetic acid has been researched along with phenylacetic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liao, F; Liu, WL; Zeng, ZC; Zhou, QX; Zuo, YP | 1 |
| Graessler, J; Kopprasch, S; Kuhlisch, E; Pietzsch, J | 1 |
| Henning, BF; Holzhausen, H; Tepel, M | 1 |
3 other study(ies) available for 4-nitrophenylacetic acid and phenylacetic acid
| Article | Year |
|---|---|
Assay of serum arylesterase activity by fitting to the reaction curve with an integrated rate equation.
Topics: Algorithms; Bilirubin; Biomarkers; Carboxylic Ester Hydrolases; Data Interpretation, Statistical; Hemoglobins; Humans; Hydrolysis; Kinetics; Phenylacetates; Triglycerides | 2001 |
Lack of association between serum paraoxonase 1 activities and increased oxidized low-density lipoprotein levels in impaired glucose tolerance and newly diagnosed diabetes mellitus.
Topics: Adult; Aged; Aryldialkylphosphatase; C-Peptide; Diabetes Mellitus, Type 2; Esterases; Female; Glucose Intolerance; Glycated Hemoglobin; Homeostasis; Humans; Insulin; Lipoproteins, LDL; Male; Middle Aged; Paraoxon; Phenotype; Phenylacetates; Substrate Specificity | 2003 |
Continuous reduction of plasma paraoxonase activity with increasing dialysis vintage in hemodialysis patients.
Topics: Analysis of Variance; Aryldialkylphosphatase; Cross-Sectional Studies; Esterases; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phenylacetates; Renal Dialysis; Time Factors | 2010 |